منابع مشابه
Cyproheptadine in severe anorexia.
A 4-year-old girl was diagnosed to have TBM on the basis of history, abnormal CSF findings and a CT scan showing moderate hydrocephalus and basal exudates. She was treated with a combination of streptomycin, isoniazid, rifampicin and pyrazinamide. She also received oral phenobarbitone for convulsions and mannitol and acetazolamide. The sensorium improved on the 6th day, only after a ventriculop...
متن کاملCyproheptadine-Induced Acute Liver Failure
We present the case of a 55-year-old white female with no history of liver or gastrointestinal disease, admitted with acute liver failure following a trial of cyproheptadine for appetite stimulation. The patient was managed with supportive care, symptomatic treatment, and discontinuation of cyproheptadine. To our knowledge, this is the first described case of cyproheptadine-induced acute liver ...
متن کاملDepression after cyproheptadine: MAO treatment.
Rohrbaugh JW, Gaillard AWK (1983): Sensory and motor aspects of contingent negative variation. In Gaillard AWK, Ritter W (eds), Tutorials in ERP Research: Endogenous Components. Amsterdam: Elsevier, pp 269-31 I. Swerdlow NR, Koob GF (1987): Dopamine, schizophrenia, mania and depression: Toward a unified hypothesis of cortico-striato-pallidothalamic function. Behav Brain Sci 10:197-245. Tyrer P,...
متن کاملA drug fatality involving Kratom.
A 17-year-old white man who showed no obvious signs of trauma was found unresponsive in bed and was pronounced dead at the scene. The decedent had a documented history of heroin abuse and chronic back pain and reportedly self-medicated with Kratom (mitragynine). The autopsy was remarkable only for pulmonary congestion and edema and a distended bladder, both of which are consistent with, though ...
متن کاملAction of cyproheptadine in spastic paraparetic patients.
The antiserotonergic agent cyproheptadine was evaluated in six patients as a medication for the management of spasticity due either to spinal cord trauma or to multiple sclerosis. Oral doses of cyproheptadine were progressively increased from 6 mg to 24 mg per day. Trial periods extended from 4 to 24 months and included a placebo substitution period. Cyproheptadine was found to decrease signifi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Analytical Toxicology
سال: 1998
ISSN: 1945-2403,0146-4760
DOI: 10.1093/jat/22.1.72